chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: M
Vaccine: FLUN3
Symptoms: Albumin CSF decreased, Alpha 1 globulin increased, Alpha 2 globulin, Ataxia, Blood glucose normal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning 22 year old, male subject, who had been received FLUMIST (intranasal) started on 30-Oct-2006. It was reported that the patient experienced Guillain Barre Syndrome which started on 03-Dec-2006. Guillain Barre Syndrome 21-Dec-2006 records received and reviewed from reporter. GBS-with ascending peripheral hyposensation. CXR (chest X-ray) revealed pulmonary edema, GBS- trach for pneumonia, transferred to ECF for rehab. Numbness began in feet then tingling in hands extending to knee and elbows. Difficulty keeping right eye opened and difficulty swallowing. On 03-Dec-2006 ataxic gait. Decreased grip and strength in lower extremities. Annual follow up information indications status of recipient recovery still unknown. Lab data includes WBC 8.9, CT negative, CSF: RBC 28, Concentrated cytospins demonstrate mononuclear leukocytes. Protein 21, glucose 54, culture negative, prealbumin 10.6, albumin 51.7, Alpha 1 G 5.6, Alpha 2 G 937, Beta G 16.1, Gamma G 6.4. All cultures negative. WBC ranged from 8.7-18.6. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to hospitalization.
Age: 22.0
Sex: M
Vaccine: FLUN3
Symptoms: CSF culture negative, CSF glucose normal, CSF protein normal, Chest X-ray abnormal, Computerised tomogram normal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning 22 year old, male subject, who had been received FLUMIST (intranasal) started on 30-Oct-2006. It was reported that the patient experienced Guillain Barre Syndrome which started on 03-Dec-2006. Guillain Barre Syndrome 21-Dec-2006 records received and reviewed from reporter. GBS-with ascending peripheral hyposensation. CXR (chest X-ray) revealed pulmonary edema, GBS- trach for pneumonia, transferred to ECF for rehab. Numbness began in feet then tingling in hands extending to knee and elbows. Difficulty keeping right eye opened and difficulty swallowing. On 03-Dec-2006 ataxic gait. Decreased grip and strength in lower extremities. Annual follow up information indications status of recipient recovery still unknown. Lab data includes WBC 8.9, CT negative, CSF: RBC 28, Concentrated cytospins demonstrate mononuclear leukocytes. Protein 21, glucose 54, culture negative, prealbumin 10.6, albumin 51.7, Alpha 1 G 5.6, Alpha 2 G 937, Beta G 16.1, Gamma G 6.4. All cultures negative. WBC ranged from 8.7-18.6. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to hospitalization.
Age: 22.0
Sex: M
Vaccine: FLUN3
Symptoms: Culture negative, Dysphagia, Grip strength decreased, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning 22 year old, male subject, who had been received FLUMIST (intranasal) started on 30-Oct-2006. It was reported that the patient experienced Guillain Barre Syndrome which started on 03-Dec-2006. Guillain Barre Syndrome 21-Dec-2006 records received and reviewed from reporter. GBS-with ascending peripheral hyposensation. CXR (chest X-ray) revealed pulmonary edema, GBS- trach for pneumonia, transferred to ECF for rehab. Numbness began in feet then tingling in hands extending to knee and elbows. Difficulty keeping right eye opened and difficulty swallowing. On 03-Dec-2006 ataxic gait. Decreased grip and strength in lower extremities. Annual follow up information indications status of recipient recovery still unknown. Lab data includes WBC 8.9, CT negative, CSF: RBC 28, Concentrated cytospins demonstrate mononuclear leukocytes. Protein 21, glucose 54, culture negative, prealbumin 10.6, albumin 51.7, Alpha 1 G 5.6, Alpha 2 G 937, Beta G 16.1, Gamma G 6.4. All cultures negative. WBC ranged from 8.7-18.6. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to hospitalization.
Age: 22.0
Sex: M
Vaccine: FLUN3
Symptoms: Immunoglobulins, Muscular weakness, Paraesthesia, Pneumonia, Prealbumin decreased
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning 22 year old, male subject, who had been received FLUMIST (intranasal) started on 30-Oct-2006. It was reported that the patient experienced Guillain Barre Syndrome which started on 03-Dec-2006. Guillain Barre Syndrome 21-Dec-2006 records received and reviewed from reporter. GBS-with ascending peripheral hyposensation. CXR (chest X-ray) revealed pulmonary edema, GBS- trach for pneumonia, transferred to ECF for rehab. Numbness began in feet then tingling in hands extending to knee and elbows. Difficulty keeping right eye opened and difficulty swallowing. On 03-Dec-2006 ataxic gait. Decreased grip and strength in lower extremities. Annual follow up information indications status of recipient recovery still unknown. Lab data includes WBC 8.9, CT negative, CSF: RBC 28, Concentrated cytospins demonstrate mononuclear leukocytes. Protein 21, glucose 54, culture negative, prealbumin 10.6, albumin 51.7, Alpha 1 G 5.6, Alpha 2 G 937, Beta G 16.1, Gamma G 6.4. All cultures negative. WBC ranged from 8.7-18.6. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to hospitalization.
Age: 22.0
Sex: M
Vaccine: FLUN3
Symptoms: Pulmonary oedema, Red blood cells CSF positive, Somnolence, Tracheostomy, White blood cell count increased
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning 22 year old, male subject, who had been received FLUMIST (intranasal) started on 30-Oct-2006. It was reported that the patient experienced Guillain Barre Syndrome which started on 03-Dec-2006. Guillain Barre Syndrome 21-Dec-2006 records received and reviewed from reporter. GBS-with ascending peripheral hyposensation. CXR (chest X-ray) revealed pulmonary edema, GBS- trach for pneumonia, transferred to ECF for rehab. Numbness began in feet then tingling in hands extending to knee and elbows. Difficulty keeping right eye opened and difficulty swallowing. On 03-Dec-2006 ataxic gait. Decreased grip and strength in lower extremities. Annual follow up information indications status of recipient recovery still unknown. Lab data includes WBC 8.9, CT negative, CSF: RBC 28, Concentrated cytospins demonstrate mononuclear leukocytes. Protein 21, glucose 54, culture negative, prealbumin 10.6, albumin 51.7, Alpha 1 G 5.6, Alpha 2 G 937, Beta G 16.1, Gamma G 6.4. All cultures negative. WBC ranged from 8.7-18.6. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to hospitalization.
Age: 19.0
Sex: F
Vaccine: FLUN4
Symptoms: Autopsy, Death, Laboratory test, Microscopy, Neurological examination
Clinical narrative: A spontaneous health professional report from a regulatory authority in an article, concerns a 19 year old female. The patient's medical history included cold sweat, nausea, dizziness, and difficulty reading numbers on the day prior to death. Concomitant medications included quadrivalent human papilloma virus vaccine and meningococcal conjugate. Patient received Nasal FLUMIST QUADRIVALENT on an unknown date. The patient died 10 days after these vaccinations from unknown causes. Despite an extensive post-mortem examination including autopsy and microscopic, neuropathological, toxicological, and chemical evaluation, the immediate cause of death could not be ascertained. Autopsy revealed no obvious cause of death. The reporter assessed the death to be serious by the criterion of death.
Age: 19.0
Sex: F
Vaccine: FLUN4
Symptoms: Toxicologic test
Clinical narrative: A spontaneous health professional report from a regulatory authority in an article, concerns a 19 year old female. The patient's medical history included cold sweat, nausea, dizziness, and difficulty reading numbers on the day prior to death. Concomitant medications included quadrivalent human papilloma virus vaccine and meningococcal conjugate. Patient received Nasal FLUMIST QUADRIVALENT on an unknown date. The patient died 10 days after these vaccinations from unknown causes. Despite an extensive post-mortem examination including autopsy and microscopic, neuropathological, toxicological, and chemical evaluation, the immediate cause of death could not be ascertained. Autopsy revealed no obvious cause of death. The reporter assessed the death to be serious by the criterion of death.
Age: 6.0
Sex: F
Vaccine: FLUN4
Symptoms: VIIth nerve paralysis
Clinical narrative: A physician report concerns a 7 year old female patient. Concomitant medications and medical history were not reported. On 13-Nov-2014, the patient received FLUMIST (intranasal). The patient experienced paralysis facial on the same day. At the time of reporting, the paralysis facial was ongoing. The reporter considered the paralysis facial to be serious based on hospitalization.
Age: 3.0
Sex: M
Vaccine: FLUN3
Symptoms: Brain injury, Death
Clinical narrative: A report from VAERS concerns a three year old male patient. The patient was born prematurely between gestational weeks 32 and 33 and suffered from atrial septal defect. The patient received nasal FLUMIST and 10 days later experienced hypoxic-ischemic brain injury. The patient died of the hypoxic-ischemic brain injury on an unknown date. It was unknown if autopsy was performed. The reporter assessed the event as serious due to death. Based on the information in this report, and awaiting the reporter's assessment, the company physician considered the event to be at least possibly related to FLUMIST.
Age: 35.0
Sex: M
Vaccine: FLUN3
Symptoms: Asthenia, Blood folate increased, Blood glucose increased, Blood thyroid stimulating hormone normal, Borrelia test negative
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 35 year old male patient. The patient's concurrent disease(s) included upper respiratory infection and erythromycin allergy. Patient had been received FLUMIST (Intranasal) started on 31-Aug-2009. It was reported that the patient developed Guillain-Barre shortly after receiving the flu via inhaled mist and for which he was hospitalized and continues to have minimal leg strength (in a wheelchair) and pain in arms/legs. Patient had inability to urinate, numbness in legs and tingling in extremities. Admitted to ICU, treatment IVF, LP, IVIG. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to disability, life threatening and hospitalization. Laboratory values and diagnostic test details are available.
Age: 35.0
Sex: M
Vaccine: FLUN3
Symptoms: CSF protein increased, Computerised tomogram head normal, Culture urine negative, Full blood count normal, Guillain-Barre syndrome
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 35 year old male patient. The patient's concurrent disease(s) included upper respiratory infection and erythromycin allergy. Patient had been received FLUMIST (Intranasal) started on 31-Aug-2009. It was reported that the patient developed Guillain-Barre shortly after receiving the flu via inhaled mist and for which he was hospitalized and continues to have minimal leg strength (in a wheelchair) and pain in arms/legs. Patient had inability to urinate, numbness in legs and tingling in extremities. Admitted to ICU, treatment IVF, LP, IVIG. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to disability, life threatening and hospitalization. Laboratory values and diagnostic test details are available.
Age: 35.0
Sex: M
Vaccine: FLUN3
Symptoms: HIV test negative, Hypoaesthesia, Immunoglobulin therapy, Intensive care, Liver function test normal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 35 year old male patient. The patient's concurrent disease(s) included upper respiratory infection and erythromycin allergy. Patient had been received FLUMIST (Intranasal) started on 31-Aug-2009. It was reported that the patient developed Guillain-Barre shortly after receiving the flu via inhaled mist and for which he was hospitalized and continues to have minimal leg strength (in a wheelchair) and pain in arms/legs. Patient had inability to urinate, numbness in legs and tingling in extremities. Admitted to ICU, treatment IVF, LP, IVIG. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to disability, life threatening and hospitalization. Laboratory values and diagnostic test details are available.
Age: 35.0
Sex: M
Vaccine: FLUN3
Symptoms: Metabolic function test normal, Nuclear magnetic resonance imaging brain normal, Nuclear magnetic resonance imaging spinal normal, Nuclear magnetic resonance imaging thoracic normal, Pain in extremity
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 35 year old male patient. The patient's concurrent disease(s) included upper respiratory infection and erythromycin allergy. Patient had been received FLUMIST (Intranasal) started on 31-Aug-2009. It was reported that the patient developed Guillain-Barre shortly after receiving the flu via inhaled mist and for which he was hospitalized and continues to have minimal leg strength (in a wheelchair) and pain in arms/legs. Patient had inability to urinate, numbness in legs and tingling in extremities. Admitted to ICU, treatment IVF, LP, IVIG. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to disability, life threatening and hospitalization. Laboratory values and diagnostic test details are available.
Age: 35.0
Sex: M
Vaccine: FLUN3
Symptoms: Paraesthesia, Protein total increased, Red blood cell sedimentation rate increased, Urinary retention, Vitamin B12 normal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 35 year old male patient. The patient's concurrent disease(s) included upper respiratory infection and erythromycin allergy. Patient had been received FLUMIST (Intranasal) started on 31-Aug-2009. It was reported that the patient developed Guillain-Barre shortly after receiving the flu via inhaled mist and for which he was hospitalized and continues to have minimal leg strength (in a wheelchair) and pain in arms/legs. Patient had inability to urinate, numbness in legs and tingling in extremities. Admitted to ICU, treatment IVF, LP, IVIG. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to disability, life threatening and hospitalization. Laboratory values and diagnostic test details are available.
Age: 35.0
Sex: M
Vaccine: FLUN3
Symptoms: Wheelchair user
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 35 year old male patient. The patient's concurrent disease(s) included upper respiratory infection and erythromycin allergy. Patient had been received FLUMIST (Intranasal) started on 31-Aug-2009. It was reported that the patient developed Guillain-Barre shortly after receiving the flu via inhaled mist and for which he was hospitalized and continues to have minimal leg strength (in a wheelchair) and pain in arms/legs. Patient had inability to urinate, numbness in legs and tingling in extremities. Admitted to ICU, treatment IVF, LP, IVIG. The outcome of the event of Guillain Barre Syndrome was unknown. The reporter considered the event Guillain Barre Syndrome to be serious due to disability, life threatening and hospitalization. Laboratory values and diagnostic test details are available.
Age: 18.0
Sex: M
Vaccine: FLUN3, HEPAB, MNQ, TDAP, TYP
Symptoms: Areflexia, Ataxia, Blood test normal, Diarrhoea, Eyelid ptosis
Clinical narrative: A report has been received from VAERS via health professional concerning a 18 year old male patient. The patient's concurrent disease included penicillin allergy. No medical history was reported for consumer. Patient had received FLUMIST (intranasal) on 11-Aug-2009. Vaccine given on same day included Diphtheria toxoid, Tetanus toxoid, Hepatitis A vaccine, Hepatitis B vaccine, Typhoid VI polysaccharide and Meningococcal Polysaccharide. This report to VAERS provides the following narrative: Medical records received for dates 10-Sep-2009 to 19-Sep-2009, patient had sinusitis with tingling in feet, hands, weakness in abdominal muscles. Patient states was unable to exercise. Symptoms had begun three days ago. Ptosis of right eye began one day ago. Sinus congestion noted five days ago then improved. Diarrhea week ago, now resolved. Patient states was given a peanut butter shot 8/4 which was standard. Patient was unable to run, do push-ups, or sit-ups. Patient states feet feeling as if they were about to fall asleep. Admitted for progression of symptoms. Assessment: ptosis right eye, areflexia, nerve conduction test abnormal-preserved latencies, ataxic, reflexes were present in morning and absent in evening. IVIG started. Patient improved on 10-Dec-2009. Outpatient Medical Records received for DOS 22-Sep-2009. Patient requesting return of full duty; reports feeling better, symptom Guillain-Barre syndrome, resolved. Reporter assessed the event Guillain Barre syndrome to be serious with criteria of Hospitalisation.
Age: 18.0
Sex: M
Vaccine: FLUN3, HEPAB, MNQ, TDAP, TYP
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture normal, Muscular weakness
Clinical narrative: A report has been received from VAERS via health professional concerning a 18 year old male patient. The patient's concurrent disease included penicillin allergy. No medical history was reported for consumer. Patient had received FLUMIST (intranasal) on 11-Aug-2009. Vaccine given on same day included Diphtheria toxoid, Tetanus toxoid, Hepatitis A vaccine, Hepatitis B vaccine, Typhoid VI polysaccharide and Meningococcal Polysaccharide. This report to VAERS provides the following narrative: Medical records received for dates 10-Sep-2009 to 19-Sep-2009, patient had sinusitis with tingling in feet, hands, weakness in abdominal muscles. Patient states was unable to exercise. Symptoms had begun three days ago. Ptosis of right eye began one day ago. Sinus congestion noted five days ago then improved. Diarrhea week ago, now resolved. Patient states was given a peanut butter shot 8/4 which was standard. Patient was unable to run, do push-ups, or sit-ups. Patient states feet feeling as if they were about to fall asleep. Admitted for progression of symptoms. Assessment: ptosis right eye, areflexia, nerve conduction test abnormal-preserved latencies, ataxic, reflexes were present in morning and absent in evening. IVIG started. Patient improved on 10-Dec-2009. Outpatient Medical Records received for DOS 22-Sep-2009. Patient requesting return of full duty; reports feeling better, symptom Guillain-Barre syndrome, resolved. Reporter assessed the event Guillain Barre syndrome to be serious with criteria of Hospitalisation.
Age: 18.0
Sex: M
Vaccine: FLUN3, HEPAB, MNQ, TDAP, TYP
Symptoms: Nerve conduction studies abnormal, Nuclear magnetic resonance imaging abnormal, Paraesthesia, Sinus congestion, Sinusitis
Clinical narrative: A report has been received from VAERS via health professional concerning a 18 year old male patient. The patient's concurrent disease included penicillin allergy. No medical history was reported for consumer. Patient had received FLUMIST (intranasal) on 11-Aug-2009. Vaccine given on same day included Diphtheria toxoid, Tetanus toxoid, Hepatitis A vaccine, Hepatitis B vaccine, Typhoid VI polysaccharide and Meningococcal Polysaccharide. This report to VAERS provides the following narrative: Medical records received for dates 10-Sep-2009 to 19-Sep-2009, patient had sinusitis with tingling in feet, hands, weakness in abdominal muscles. Patient states was unable to exercise. Symptoms had begun three days ago. Ptosis of right eye began one day ago. Sinus congestion noted five days ago then improved. Diarrhea week ago, now resolved. Patient states was given a peanut butter shot 8/4 which was standard. Patient was unable to run, do push-ups, or sit-ups. Patient states feet feeling as if they were about to fall asleep. Admitted for progression of symptoms. Assessment: ptosis right eye, areflexia, nerve conduction test abnormal-preserved latencies, ataxic, reflexes were present in morning and absent in evening. IVIG started. Patient improved on 10-Dec-2009. Outpatient Medical Records received for DOS 22-Sep-2009. Patient requesting return of full duty; reports feeling better, symptom Guillain-Barre syndrome, resolved. Reporter assessed the event Guillain Barre syndrome to be serious with criteria of Hospitalisation.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Alanine aminotransferase increased, Antinuclear antibody negative, Areflexia, Aspartate aminotransferase increased, Asthenia
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Ataxia, Autonomic nervous system imbalance, Balance disorder, Blood creatine phosphokinase increased, Blood lactic acid increased
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Blood potassium decreased, C-reactive protein normal, CSF glucose decreased, Carpal tunnel syndrome, Culture negative
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Differential white blood cell count normal, Dysphagia, Facial paresis, Full blood count normal, Gram stain negative
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Guillain-Barre syndrome, Headache, Hypoaesthesia, Immunoglobulin therapy, Intervertebral disc disorder
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Intervertebral disc protrusion, Laboratory test normal, Lumbar puncture, Lumbar radiculopathy, Lymphocyte count decreased
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Mean platelet volume normal, Muscular weakness, Nausea, Nerve conduction studies, Neutrophil count increased
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Nuclear magnetic resonance imaging spinal abnormal, Orthostatic hypotension, Paraesthesia, Polymerase chain reaction, Productive cough
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.